Characteristics | Response | Frequency | Percentage |
---|---|---|---|
Opportunistic infection at baseline | Yes | 159 | 52.1 |
No | 146 | 47.9 | |
Types of opportunistic disease (more than one disease were observed) | Herpes zoster | 44 | 14.4 |
Tuberculosis | 23 | 7.5 | |
Persistent fever >1 month | 15 | 9.4 | |
Chronic diarrheal disease | 18 | 11.3 | |
Weight loss >10% | 13 | 8.2 | |
Weight loss <10% | 22 | 7.2 | |
Oral candidiasis | 22 | 7.2 | |
Bacterial pneumonia | 10 | 3.3 | |
Toxoplasmosis | 6 | 2 | |
Cryptococcusis | 2 | 0.7 | |
Baseline WHO stage | stage 1 | 155 | 50.8 |
stage 2 | 62 | 20.3 | |
stage 3 | 79 | 25.9 | |
stage 4 | 9 | 3 | |
Baseline functional status | Working | 271 | 88.9 |
Ambulatory | 31 | 10.2 | |
Bed ridden | 3 | 1 | |
Baseline CD4 count (cell/dl) | Less than 200 | 96 | 31.5 |
200–350 | 90 | 29.5 | |
351–500 | 62 | 20.3 | |
>500 | 57 | 18.7 | |
Treatment regiment | 1e (TDF-3TC-EFV) | 199 | 65.2 |
Other Regimena | 106 | 34.8 | |
Change in treatment regimen | Yes | 58 | 19 |
No | 247 | 81 | |
ART adherence | Good | 293 | 96.1 |
Poor | 12 | 3.9 |